NCCN Guidelines Panel Disclosures

Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Pamela Sue Becker, MD, PhD	None	Alder Biopharmaceuticals	None	None	3/27/2010
Charles L. Bennett, MD, PhD, MPP	None	National Center for Medical Education	None	None	4/13/2010
Morey Blinder, MD					Pending
David Cella, PhD	None	None	None	None	1/5/2010
Asher Chanan-Khan, MD	Celgene Corporation; Millennium Pharmaceuticals, Inc.	Celgene Corporation; Millennium Pharmaceuticals, Inc.	None	None	11/3/2009
Charles Cleeland, PhD	None	None	None	None	8/16/2010
Peter F. Coccia, MD	None	None	None	None	7/1/2009
Benjamin Djulbegovic, MD, PhD	Millennium Pharmaceuticals, Inc.	None	None	None	9/29/2009
Mary Dwyer, MS	None	None	None	None	7/15/2010
Lauren Gallagher, RPh, PhD	None	None	None	None	8/23/2010
Jeffrey A. Gilreath, PharmD	None	None	None	None	9/28/2009
Kristina M. Gregory, RN, MSN, OCN	None	None	None	None	8/30/2010
Maria Ho, PhD	None	None	None	None	7/15/2010
Eric H. Kraut, MD	None	None	None	None	7/10/2009
Ursula A. Matulonis, MD	AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Genentech, Inc.; Merck & Co., Inc.	Eisai Inc.; Merck & Co., Inc.	None	None	10/9/2009
Joan S. McClure, MS	None	None	None	None	7/18/2010
Michael M. Millenson, MD, FACP	None	Amgen Inc.; Celgene Corporation; GlaxoSmithKline	None	sanofi-aventis U.S.	12/8/2009
Denise Reinke, APRN, BC, AOCN	None	None	None	None	11/4/2009
George M. Rodgers, MD, PhD	None	Amgen Inc.; AMAG; Watson Pharmaceuticals, Inc.	None	None	2/18/2010
Joseph Rosenthal, MD	None	None	None	None	10/13/2009
Rowena N. Schwartz, PharmD, BCOP	None	None	None	None	6/15/2010
Gerald Soff, MD					Pending
Richard S. Stein, MD	None	None	None	None	9/29/2009
Gordana Vlahovic, MD					Pending
Alva B. Weir, III, MD	None	None	None	None	9/3/2009

NCCN Website Supporters

National Comprehensive Cancer Network

About NCCN